You are here

SIRT Slows Liver Metastases in Colorectal Cancer

Dr. Peter Gibbs, a medical oncologist at Royal Melbourne Hospital in Australia, says hepatic disease progression among metastatic colorectal cancer patients with liver-dominant metastases was reduced in the SIRFLOX trial when selective internal radiation therapy (SIRT) was added to a standard first-line chemotherapy regimen.

American Society of Clinical Oncology 2015 Annual Meeting, Chicago